| Prostate Adenocarcinoma studied in …STUDIED_INderived200 of 433show all (up to 200) |
|---|
| → studied in | NCT06369610Phase 2 · active not recruiting Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025369Phase 2 · recruiting Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04053842Phase 2 · completed Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985565NA · active not recruiting Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650240Phase 2 · recruiting Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05003752Phase 1/Phase 2 · active not recruiting Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05616650Phase 2 · recruiting Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665738NA · recruiting Two-fraction HDR Monotherapy for Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06205316Phase 3 · active not recruiting SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04286386withdrawn Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02703623Phase 2 · active not recruiting Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807065Phase 2 · completed Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05946213Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03317392Phase 1/Phase 2 · active not recruiting Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06470750completed Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP) · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03762759Phase 2 · active not recruiting Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06931340Phase 3 · recruiting Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07200830Phase 3 · recruiting Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05710380NA · recruiting MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05726292Phase 2 · recruiting A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654336Phase 2 · recruiting Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC) · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07466498Phase 2 · not yet recruiting Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Castration-Sensitive Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03371719Phase 2 · active not recruiting Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06982222Phase 1 · withdrawn Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03204123Phase 2 · active not recruiting PSMA PET Imaging of Recurrent Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03442556Phase 2 · terminated Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022822Phase 2 · recruiting Placebo-Controlled Trial of Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy, URO-PRO Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04019327Phase 1/Phase 2 · terminated A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04945642NA · recruiting High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995053NA · active not recruiting Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423211Phase 3 · recruiting Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04134260Phase 3 · active not recruiting Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050084Phase 3 · active not recruiting Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05053152Phase 2 · active not recruiting Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06957691Phase 2 · recruiting Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01953640completed Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235151Phase 3 · active not recruiting Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07766486NA · active not recruiting Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation Therapy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03624660Phase 2 · active not recruiting Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04126070Phase 2 · active not recruiting Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786265Phase 2 · active not recruiting Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06236139Phase 1/Phase 2 · recruiting Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06257693Phase 1 · recruiting Enzalutamide Implants (Enolen) in Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02949284Phase 2 · active not recruiting Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04519879Phase 2 · suspended White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05832086Phase 2 · recruiting Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03419234Phase 2 · active not recruiting Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05610852NA · recruiting Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06145633Phase 2 · recruiting Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04030338active not recruiting Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07364071Phase 2 · recruiting Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893917Phase 2 · active not recruiting Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751434Phase 2 · recruiting A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06325046NA · recruiting Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246347Phase 2 · active not recruiting A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03456843Phase 2 · active not recruiting Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05113537Phase 1/Phase 2 · recruiting Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04471974Phase 2 · active not recruiting ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06238713NA · recruiting Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP) · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01352429active not recruiting Mild Hypofractionation With Proton Therapy or IMRT for Intermediate-Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03796767Phase 2 · completed Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05689021Phase 2 · terminated CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06039371Phase 2 · recruiting Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04743934Phase 2 · completed Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04915508Phase 2 · active not recruiting Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06067269Phase 2 · recruiting Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691465Phase 2 · recruiting Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma with Neuroendocrine Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04037254Phase 1/Phase 2 · completed Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03274687Phase 3 · completed Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175431Phase 2 · recruiting Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04624256NA · active not recruiting Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07042256NA · recruiting Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07552168Phase 2 · recruiting INSPIRE: INnovative SABR for Prostate Cancer All IREland · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02346253NA · completed High-Dose Brachytherapy in Treating Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05852041early Phase 1 · recruiting rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06813898early Phase 1 · recruiting An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07574489Phase 2/Phase 3 · not yet recruiting Whole Versus Partial Gland Boost During Prostate SBRT · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02206334Phase 1 · completed Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02217709Phase 2 · completed Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530552Phase 2 · completed Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07635238Phase 2 · recruiting A Study of Lower Dose Radiation Therapy for People With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07656337NA · not yet recruiting Effects of Direct Artery Injection on Prostate Cancer Drug Delivery and Tumor Uptake: Imaging-Based Prediction of Treatment Effectiveness · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01950351Phase 2 · active not recruiting Hypofractionated Proton Beam Therapy for Localized Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06392295Phase 2 · recruiting PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06967961NA · recruiting Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07641049Phase 1 · recruiting Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899987Phase 2 · active not recruiting Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04190446Phase 2 · active not recruiting A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05168618Phase 2 · recruiting Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06499870Phase 2 · recruiting Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03821246Phase 2 · recruiting Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048150Phase 1 · completed Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03570827Phase 2 · completed Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05496959Phase 2 · active not recruiting 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03503643completed Hemi-Gland Cryoablation for Prostate Cancer at UCLA · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04687969completed Multimodal Machine Learning Characterization of Solid Tumors · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05931419recruiting High-Risk prostatE Cancer radiatiOn Versus surgERy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07468903NA · recruiting Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03933670Phase 2 · recruiting Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544830Phase 2 · active not recruiting Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761889NA · completed Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04384770active not recruiting CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04486755Phase 1 · active not recruiting Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03880422NA · recruiting Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07568756Phase 2 · not yet recruiting Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01411345NA · active not recruiting MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06616155Phase 1/Phase 2 · recruiting Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04465500Phase 2 · active not recruiting EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03821792Phase 2 · active not recruiting Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05055843NA · active not recruiting Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05960578Phase 2 · active not recruiting Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06044857Phase 1 · recruiting PSMA PET Response Guided SabR in High Risk Pca · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03361735Phase 2 · active not recruiting Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04300855Phase 2 · active not recruiting Clinical Trial of Green Tea Catechins in Men on Active Surveillance · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06798558Phase 2 · recruiting Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412396Phase 2 · active not recruiting Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03360721Phase 2 · terminated Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma without Neuroendocrine Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06173362Phase 2 · recruiting Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06330805Phase 2 · recruiting Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04288687Phase 2 · completed A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409200Phase 2 · completed Antiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node Metastasis · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05676463Phase 2 · terminated MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04943536Phase 1 · active not recruiting Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02296229NA · active not recruiting Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07285057Phase 2 · recruiting Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06235099Phase 3 · completed Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05683964early Phase 1 · active not recruiting Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01517451Phase 1/Phase 2 · completed Radiation and Androgen Ablation for Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04704505Phase 2 · recruiting Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04754425Phase 2 · terminated Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03902951Phase 2 · active not recruiting Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04455750Phase 3 · active not recruiting A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07276438NA · recruiting Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05806515Phase 2 · recruiting Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734730Phase 2 · recruiting Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03503344Phase 2 · completed Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03367702Phase 3 · active not recruiting Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04777071Phase 2 · active not recruiting An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870515NA · completed Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06822491active not recruiting Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04446117Phase 3 · active not recruiting Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05998278NA · recruiting Personalized Optimization of Systematic Prostate Biopsy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06200259NA · recruiting Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02600156NA · completed Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06347809terminated DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06105918Phase 1 · active not recruiting Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03511196early Phase 1 · active not recruiting Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05064111suspended Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04543903NA · completed Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07251829Phase 2 · not yet recruiting Neoadjuvant Embolization and Cytoreduction in Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02023463Phase 1 · active not recruiting Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541850Phase 2 · active not recruiting Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860961NA · completed Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02203695Phase 2 · completed Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05779943Phase 2 · active not recruiting Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05919329Phase 4 · recruiting Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141993recruiting ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07210502NA · not yet recruiting Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04616547Phase 2 · terminated Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276492Phase 1 · terminated Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03516812Phase 2 · completed Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528210Phase 2 · withdrawn Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05445609Phase 2 · suspended Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179783Phase 2 · recruiting Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC) · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma with Neuroendocrine Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05733351Phase 1 · terminated Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01655836Phase 1 · active not recruiting High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600400NA · recruiting Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02470897NA · completed Stereotactic Body Radiation Therapy With Boost Using Urethral-Sparing Intensity-Modulated Radiation Therapy Planning in Treating Patients With Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05027477NA · active not recruiting A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04336943Phase 2 · terminated Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01952223Phase 3 · active not recruiting A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03963739completed Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03432897Phase 2 · terminated BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05796973Phase 3 · recruiting Measuring Oncological Value of Exercise and Statin · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400656completed PROState Pathway Embedded Comparative Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06312670Phase 2 · completed Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278185Phase 2 · completed Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01848067Phase 1/Phase 2 · completed Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02603965Phase 1 · completed Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02983279NA · completed Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Acinar Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03076203Phase 1 · completed Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad) · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03689699Phase 1/Phase 2 · active not recruiting Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03581500Phase 2 · withdrawn Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03654638Phase 2 · completed Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04049747NA · completed Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04428203Phase 1 · completed Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06850545recruiting Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03805594Phase 1 · completed 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902637NA · completed The Efficacy of Mapping for Cognitive Prostate Biopsy · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03822494NA · active not recruiting CyberKnife Dose Escalation Prostate Cancer Trial · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02254746NA · completed A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02176902NA · active not recruiting Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer · condition mapped ALIAS · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05479578Phase 1 · active not recruiting Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer · condition mapped CURATED_BROADER · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04951492Phase 2 · terminated Olaparib for the Treatment of Castration Resistant Prostate Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06736054Phase 1 · recruiting A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001477recruiting Customized TULSA-PRO Ablation Registry · condition mapped ONTOLOGY_EXACT · 433 trials mapped (146 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |